Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | NQO2 | P16083 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA7 | P43166 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2253346 | 0.87 | CYP1A2 (0.55) | CYP1A2CYP2A6ACHERAB9AKDM4E | |
| SCHEMBL2254030 | 0.87 | CYP1A2 (0.55) | CYP1A2CYP2A6ACHERAB9AKDM4E | |
| SCHEMBL152913 | 0.85 | CYP1A2 (0.55) | CYP1A2CYP2A6ACHERAB9AKDM4E | |
| SCHEMBL2251601 | 0.80 | NQO1 (0.43) | CYP1A2KDM4EMEN1POLBKMT2A | |
| SCHEMBL7197663 | 0.80 | CYP1A2 (0.33) | CYP1A2CYP2A6 | |
| SCHEMBL27961290 | 0.79 | CYP1A2 (0.48) | CYP1A2CYP2A6ACHERAB9AKDM4E | |
| Magnesium Chloride Anhydrous SCHEMBL28811729 | 0.79 | CYP1A2 (0.48) | CYP1A2CYP2A6ACHERAB9AKDM4E | |
| SCHEMBL5543057 | 0.77 | GPR3 (0.40) | CYP1A2RAB9AKDM4EKMT2ANPC1 | |
| SCHEMBL6583460 | 0.76 | CYP1A2 (0.31) | CYP1A2CYP2A6 | |
| SCHEMBL6048370 | 0.75 | CA1 (0.43) | CYP1A2CYP2A6ACHERAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117983302-A | Catalyst containing ferrocene PNP ligand for ethylene selective tetramerization and preparation method and application thereof | 华东理工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-107353229-B | A kind of preparation method of agomelatine intermediate body | 许昌恒生制药有限公司 | 2019-04-30 | — | — | CN | claimed |
| CN-104230754-B | A kind of synthetic method of (7-methoxy-1-naphthyl) acetonitrile | ZHEJIANG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2017-01-04 | — | — | CN | claimed |
| CN-104557591-B | A kind of method preparing agomelatine acetyl diamines | 扬子江药业集团四川海蓉药业有限公司 | 2016-09-07 | — | — | CN | claimed |
| CN-102234238-B | Method for preparing 2-(7-methoxy-1-naphthyl) ethylamine industrially | SHANGHAI INST PHARM INDUSTRY | 2014-06-18 | — | — | CN | claimed |
| CN-103073441-A | Novel method for compositing (7- methoxy-1-naphthyl) and application of method in compositing of agomelatine | SHANGHAI RIGHT HAND MEDICAL TECHNOLOGY DEV CO LTD | 2013-05-01 | — | — | CN | claimed |
| CN-101538201-B | Preparation method of agomelatine midbody (7-methoxyl group-1-naphthyl) acetic ester | SHANGHAI INST PHARM INDUSTRY | 2013-03-06 | — | — | CN | claimed |
| CN-101792400-B | Synthetic method for agomelatine | UNIV EAST CHINA NORMAL | 2013-01-30 | — | — | CN | claimed |
| US-6509426-B2 | Dichloro(1,1'-dimethylsilylenebis(2-methyl-4-(4-methoxyphenyl) -4H-azulenyl))zirconium, for example; can produce polyolefin with high molecular weight and high melting point for extrusion or injection moldability | JAPAN POLYCHEM CORPORATION (JP) | 2003-01-21 | — | — | US | claimed |
| US-6127357-A | N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides | JOHN WYETH & BROTHER, LTD. (GB) | 2000-10-03 | — | — | US | claimed |
| EP-0512755-B1 | Piperazine derivatives | WYETH JOHN & BROTHER LTD (GB) | 1994-12-14 | — | — | EP | claimed |
| EP-0354093-B1 | Piperazine derivatives and process for their preparation | SYNTHELABO (FR) | 1993-12-22 | — | — | EP | claimed |
| EP-0512755-A2 | Piperazine derivatives | JOHN WYETH & BROTHER LIMITED (GB) | 1992-11-11 | — | — | EP | claimed |
| EP-0354094-B1 | INDOLONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTICAL USE | SYNTHELABO (FR) | 1991-12-27 | — | — | EP | claimed |
| US-5010079-A | Treatment of psychological disorders | SYNTHELABO (FR) | 1991-04-23 | — | — | US | claimed |
| US-4963680-A | INTERMEDIATES FOR THERAPEUTIC DRUGS | SYNTHELABO (FR) | 1990-10-16 | — | — | US | claimed |
| JP-2073062-A | — | — | None | — | — | JP | disclosed |
| JP-2073075-A | — | — | None | — | — | JP | disclosed |
| EP-0006217-A1 | Substituted amino acids, their use and preparation, and compositions containing them | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1980-01-09 | — | — | EP | disclosed |
| US-4139537-A | 3-Aryloxy-1-(2- or 4-iminodihydro-1-pyridyl)-2-propanol antiarrhythmic compounds | COOPER LABORATORIES, INC. (US) | 1979-02-13 | — | — | US | disclosed |